Herrmann Ken bought AKTS

July 20, 2026 · Form 4 insider transaction

Herrmann Ken bought 1,350 shares of Aktis Oncology, Inc. at $1.91 per share, a transaction worth $2.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
1,350
Price
$1.91
Total value
$2.6K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 20, 2026
Filing dateJuly 21, 2026
Shares owned after4,856
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR
Herrmann Ken bought AKTS: July 20, 2026 | Insider Trading Screener